Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Cervical Cancer, January 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 230 articles: HTML format

Single Articles

1. SHI A, Yerebake M, Du Z, Li L, et al
   Acupuncture as adjunctive therapy for cervical cancer pain: a systematic review and meta-analysis.
   J Pain Symptom Manage. 2025 Dec 31:S0885-3924(25)01021.
   Abstract
   
   
2. PANT S
   ACS: New Cervical Cancer Screening Guidelines.
   JAMA. 2026 Jan 2. doi: 10.1001/jama.2025.23004.
   Abstract
   
   
3. WANG F, Wang L, Bai Y
   Research progress of ferroptosis in cervical cancer treatment.
   Ann Med. 2026;58:2611208.
   Abstract
   
   
4. ZHANG J, Fu C, Du J
   Artificial intelligence-assisted noninvasive preoperative prediction of lymph nodes metastasis in cervical cancer through a clinical-imaging feature combined strategy.
   Front Oncol. 2025;15:1669396.
   Abstract
   
   
5. BUSTOS-GUTIERREZ MT, Morales-Casetti ML, Vasquez-Palma OA, Bustos-Gutierrez LR, et al
   [Social determinants of health that influence pap smear and mammography screening in Chilean women].
   Rev Salud Publica (Bogota). 2025;27:114162.
   Abstract
   
   
6. HIRAKAWA A, Iwai N, Yanai A, Matsukawa K, et al
   Efficacy of Sentinel Lymph Node Sampling for Early Cervical Cancer: A Single Institute Study.
   J Obstet Gynaecol Res. 2026;52:e70144.
   Abstract
   
   
7. TANG C, Jin X
   Deubiquitinating enzymes in endometrial cancer and cervical cancer.
   Gene. 2025 Dec 30:149988. doi: 10.1016/j.gene.2025.149988.
   Abstract
   
   
8. LIU T, Zhang L, Li Y, Liao W, et al
   Glutamine metabolites promote the progression of cervical cancer by inducing M2 macrophage polarization.
   Pathol Res Pract. 2025;278:156348.
   Abstract
   
   
9. RAJI PS, Thomas A, Thomas DS, Thomas V, et al
   Compliance to Standards of Colposcopy in an Effort to Reduce the Cervical Cancer Burden: An Audit.
   J Obstet Gynaecol India. 2025;75:461-466.
   Abstract
   
   
10. ASFAW MS, Kassahun W
    The role of microRNAs on autophagy in cervical cancer: review.
    Discov Oncol. 2025 Dec 31. doi: 10.1007/s12672-025-04284.
    Abstract
    
    
11. PINGAULT O, Moskal A, Bouvard C, Payet C, et al
    Gynaecological follow-up of adolescent and young adult cancer survivors: a comparative cohort study.
    BMJ Open. 2025;15:e108897.
    Abstract
    
    
12. ASARE M, Ebu Enyan NI, Sencherey VL, Lamptey-Mills E, et al
    Culturally adapting and evaluating an evidence-based communication intervention with HPV self-sampling to improve cervical cancer screening among women living with HIV in Ghana: a mixed-methods study.
    BMJ Open. 2025;15:e105852.
    Abstract
    
    
13. LU X, Feng L, Zhang L, Gu F, et al
    Covalently assembled dual-functional triple-helix lentinan-Au for cervical cancer therapy.
    Carbohydr Polym. 2026;375:124799.
    Abstract
    
    
14. TUERXUN H, Li J, Liu Q, Tursun M, et al
    MICA/B-Driven NK Cell Dysfunction Promotes Cervical Cancer via Toll Signaling.
    Exp Cell Res. 2025 Dec 29:114876. doi: 10.1016/j.yexcr.2025.114876.
    Abstract
    
    
15. REN Y, Li S, Xiang S, Xu J, et al
    A Retrospective Study on the Clinicopathological Characteristics and Prognostic Analysis of Gynecologic Neuroendocrine Carcinoma.
    Cancer Med. 2026;15:e71488.
    Abstract
    
    
16. SHARMA H, Soni KK, Thakur N, Kumar M, et al
    Intracavitary brachytherapy challenge in cervical cancer with a large cervical fibroid: A case report.
    J Cancer Res Ther. 2025;21:1431-1434.
    Abstract
    
    
17. ABRAHAM P
    Human Papillomavirus Vaccination - A Moment of Prevention, a Lifetime of Protection.
    Indian J Public Health. 2025;69:375-376.
    Abstract
    
    
18. KIM CA, Shelton N, Samudrala M, Savsani K, et al
    AutoEpiCollect 2.0: A Web-Based Machine Learning Tool for Personalized Peptide Cancer Vaccine Design.
    Molecules. 2025;30:4702.
    Abstract
    
    
19. KIM MH, Yang J, Song DH, Kim CH, et al
    Expression of Core Hippo Pathway Proteins in Cervical Cancer and Their Association with Clinicopathologic Parameters.
    Medicina (Kaunas). 2025;61:2134.
    Abstract
    
    
20. TERKIMBI SD, Paul-Chima UO, Mujinya R, Joan C, et al
    Molecular, immunological and oncogenic mechanisms of cervical cancer mediated by HPV/HIV co-infection, clinical implication and management.
    Infect Agent Cancer. 2025 Dec 30. doi: 10.1186/s13027-025-00729.
    Abstract
    
    
21. HOSHINO N, Yoshida K, Kanemitsu Y, Toyama A, et al
    Individualized Estimated Glomerular Filtration Rate-based Renal Function Association With Cisplatin Treatment Completion in Cervical Cancer.
    Anticancer Res. 2026;46:273-281.
    Abstract
    
    
22. OOMMEN AM, Ashfaq M, Tonsing MV, Cherian AG, et al
    Protocol for a cervical screening implementation trial comparing two approaches for delivering HPV self-collection in low-resource settings in India: a type 3 hybrid cluster randomised controlled trial (SHE-CAN).
    BMJ Open. 2025;15:e101599.
    Abstract
    
    
23. ABASCAL MIGUEL L, Gaitan Barrillas R, Johnston JS, Ward V, et al
    HPV vaccine awareness and uptake in rural Indigenous communities in Guatemala: a cross-sectional study.
    BMJ Open. 2025;15:e107602.
    Abstract
    
    
24. PRETI M, Lewis F, Carcopino X, Bevilacqua F, et al
    Vulvar Inspection at the Time of Cervical Cancer Screening: European Society of Gynecological Oncology (ESGO), International Society for the Study of Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease (ECSVD), and European
    Obstet Gynecol Surv. 2025;80:759-761.
    Abstract
    
    
25. DESCAMPS P, Dixon S, Bosch Jose FX, Kyrgiou M, et al
    Turning the Tide: Recommendations to Increase Cervical Cancer Screening Among Women Who Are Underscreened.
    Obstet Gynecol Surv. 2025;80:702-704.
    Abstract
    
    
26. MKUU RS, Tohme S, Rivero-Mendoza D, Salloum RG, et al
    Improving Patient Education Materials for HPV Self-Collection: Insights from Women at High Risk of Developing Cervical Cancer.
    Cancer Manag Res. 2025;17:3273-3284.
    Abstract
    
    
27. DONG S, Feng YN, Li XY, Peng YQ, et al
    An Ultrasound Radiomics Model for the Early Diagnosis of Cervical Cancer.
    Ultrason Imaging. 2025 Dec 29:1617346251403960. doi: 10.1177/01617346251403960.
    Abstract
    
    
28. YAN Q, Zhang Z, Li R, Xue J, et al
    Clinical and nutritional-inflammatory biomarkers-based nomogram predicts survival in recurrent or metastatic cervical cancer treated with immune checkpoint inhibitors.
    Ann Med. 2026;58:2603780.
    Abstract
    
    
29. OOMMEN AM, Ashfaq M, Viswanathan V, Singarayar P, et al
    Readiness to transition to HPV self-collection from VIA screening: a mixed methods health systems assessment from Tamil Nadu, India.
    BMC Health Serv Res. 2025;25:1619.
    Abstract
    
    
30. ISMAEL AMEEN S, Masoudi M, Azizi H, Skutella T, et al
    HPV-Driven Immune Evasion in Cervical Cancer: Transcriptomic Identification of Downregulated Hub Genes and Suppressed Leukocyte Migration Pathways.
    Int J Mol Sci. 2025;26:12121.
    Abstract
    
    
31. RODRIGUEZ-NAVA C, Cortes-Sarabia K, Riano-Umbarila L, Becerril-Lujan B, et al
    Generation of a scFv Derived from an IgM-Producing Hybridoma for the Detection of REST Expression in Premalignant Lesions and Invasive Squamous Cell Carcinoma.
    Int J Mol Sci. 2025;26:11946.
    Abstract
    
    
32. OPLAWSKI M, Mawlichanow K, Golec-Cera A, Jedrzejczyk A, et al
    Outcomes of Cervical Cancer Treatment Using Total Mesometrial Resection (TMMR) Performed with the Robotic System-A Preliminary Report.
    J Clin Med. 2025;14:8667.
    Abstract
    
    
33. GRIECO V, Fiorito D, Giorgianni G, Irato E, et al
    HPV Vaccine: An Effective but Underutilized Prevention Tool.
    Int J Environ Res Public Health. 2025;22:1844.
    Abstract
    
    
34. GISCA T, Matasariu DR, Ursache A, Socolov DG, et al
    Integrating Biomarkers into Cervical Cancer Screening-Advances in Diagnosis and Risk Prediction: A Narrative Review.
    Diagnostics (Basel). 2025;15:3231.
    Abstract
    
    
35. JIANG Y, Wei Y, Li Z, Huang Z, et al
    Enhancing CD8(+) T Cells Infiltration Through the Protein Arginine Methyltransferase 5 (PRMT5)/CXCL10 Axis Restricts Cervical Cancer Progression.
    Biomolecules. 2025;15:1717.
    Abstract
    
    
36. PHIANPISET R, Detwongya C, Phookiaw S, Manopunya M, et al
    Long-Term Oncological Outcomes of Laparoscopic Versus Open Radical Surgery in Early-Stage Cervical Cancer: A Propensity Score-Matched Analysis.
    Cancers (Basel). 2025;17:3960.
    Abstract
    
    
37. SANTOS F, Caramelo FA, Tomaz JMP, Santana MM, et al
    Exosomes as Emerging Non-Invasive Biomarkers of Cervical Cancer: A Systematic Review and Meta-Analysis.
    Cancers (Basel). 2025;17:3945.
    Abstract
    
    
38. SONG Y, Zou K, Zou L
    Treatment of Pelvic Recurrence After Radiotherapy for Cervical Cancer.
    Cancers (Basel). 2025;17:3934.
    Abstract
    
    
39. GACUTA E, Lawicki M, Grabowska H, Lawicki P, et al
    Role of Matrilysins (MMP-7, MMP-26) and Stromelysins (MMP-3, MMP-10) in Diagnosing Cervical Cancer Patients.
    Biomedicines. 2025;13:2910.
    Abstract
    
    
40. RUHODE N, Madanhire C, Tumushime MK, Gudukeya S, et al
    Perceptions of integrating cervical cancer screening with HIV and sexual and reproductive health services: results from serial multiple methods studies among health workers and women in Zimbabwe.
    Reprod Health. 2025;22:259.
    Abstract
    
    
41. A AMER A, Altabbaa H, Sh Ramadan M, Abdul-Hafez HA, et al
    A multinational cross-sectional study on human papillomavirus and cervical cancer knowledge, vaccination attitudes, and risk factors in the Middle East.
    Sci Rep. 2025 Dec 29. doi: 10.1038/s41598-025-30866.
    Abstract
    
    
42. FANT C, Tewari K
    Eradicating cervical cancer in the poorest regions of the world.
    Curr Opin Obstet Gynecol. 2026;38:6-13.
    Abstract
    
    
43. RAO S, R S, Sarma D, Nath AG, et al
    HPV Screening in Women Living with HIV (WLHIV) in Karnataka, India: Can it be Integrated into ART Centres?
    Asian Pac J Cancer Prev. 2025;26:4513-4523.
    Abstract
    
    
44. BOMUANG K, Saengkhiao M, Chaimay B, Woradet S, et al
    Health Literacy and Factors Associated with HPV Vaccination among Adolescent Students: A Cross-Sectional Analytic Study.
    Asian Pac J Cancer Prev. 2025;26:4387-4396.
    Abstract
    
    
45. SINGH N, Mangal S, Tanwar P, Singhal S, et al
    Evaluating The Feasibility and Acceptability of Cervical Cancer Screening in an Urban Slum Community by HPV Self-Sampling With the Aid of Telecounselling: Lessons Learnt.
    Asian Pac J Cancer Prev. 2025;26:4331-4338.
    Abstract
    
    
46. LEE HY, Chipalo E, Luo Y, Chou C, et al
    Determinants of Female Cancer Screening Awareness in Alabama's Black Belt Region.
    Asian Pac J Cancer Prev. 2025;26:4313-4322.
    Abstract
    
    
47. K C BHANDARI A, Htay ZW, Parvin R, Murakami M, et al
    Prevalence of Cervical Cancer Screening in Asia: A Systematic Review and Meta-Analysis.
    Asian Pac J Cancer Prev. 2025;26:4269-4281.
    Abstract
    
    
48. KRYLYSHKIN M, Chernyakov A, Dil O, Truschuk J, et al
    Radical Trachelectomy Using A Titanium-Nickelide Metal Tricotage Implant to Preserve Fertility in Cervical Cancer Patients.
    Asian Pac J Cancer Prev. 2025;26:4265-4268.
    Abstract
    
    
49. AZHARI HA, Chawdhury M, Islam F, Zakaria GA, et al
    Visual inspection with acetic acid and colposcopy: screening of cervical cancer in resource-limited healthcare settings.
    Front Glob Womens Health. 2025;6:1684205.
    Abstract
    
    
50. WU X, Wang D, Mao X, Dong B, et al
    Microbiome-Driven Resistance in Cervical Cancer Therapy: From Mechanistic Dissection to Clinical Translation.
    Expert Rev Mol Med. 2025 Dec 29:1-45. doi: 10.1017/erm.2025.10029.
    Abstract
    
    
51. BLETSAS M, Rodrigues M
    [Tisotumab Vedotin - Metastatic or recurrent cervical cancer as second-line therapy].
    Bull Cancer. 2025 Dec 27:S0007-4551(25)00534.
    Abstract
    
    
52. ZHANG J, Zhao J, Cui RR, Wang TT, et al
    [Clinical outcomes of people with abnormal cervical cancer screening results but normal colposcopy findings].
    Zhonghua Fu Chan Ke Za Zhi. 2025;60:958-967.
    Abstract
    
    
53. SULTANOV M, Pan F, Naheed N, Rahman A, et al
    Costing of Cervical Cancer Screening and Treatment Pathways: Case Studies in Bangladesh and Uganda.
    Value Health Reg Issues. 2025;54:101566.
    Abstract
    
    
54. MANGA SM, Lee GM, Ekoue N, Simeni MH, et al
    Prevalence of human papillomavirus and cervical neoplasia among women who have sex with women in Cameroon: A descriptive study.
    Afr J Reprod Health. 2025;29:122-130.
    Abstract
    
    
55. PAKDAMAN K, Esmaeilnia Shirvani A, Pakdaman K, Karim B, et al
    Systematic review and meta analysis of the global incidence and clinicopathological characteristics of liver metastasis in patients with cervical cancer.
    Discov Oncol. 2025 Dec 27. doi: 10.1007/s12672-025-04255.
    Abstract
    
    
56. ADEKUNLE TE, Adekunle TB, Thomas S
    Black Women's Perceptions of the Challenges Surrounding Cervical Cancer Screening in the United States.
    J Racial Ethn Health Disparities. 2025 Dec 27. doi: 10.1007/s40615-025-02809.
    Abstract
    
    
57. YIN J, Zhang S, Wang S, Li Z, et al
    Age-specific clinical performance of HPV-based vs. cytology-based cervical cancer screening in China.
    Nat Commun. 2025 Dec 27. doi: 10.1038/s41467-025-67215.
    Abstract
    
    
58. MONTECILLO JAV, Yoo HJ, Lee YY, Park CM, et al
    Streptococcus vaginalis affects cellular dynamics of cervical cancer cells via oxidative stress-induced activation of endoplasmic reticulum unfolded protein response.
    Microbiol Res. 2025;305:128433.
    Abstract
    
    
59. VILLARREAL XP, He R, Valle D, Kioutchoukova IP, et al
    Preferences of High-Risk HPV-Based Cervical Cancer Screening among Transgender Men and Gender Diverse People Assigned Female at Birth: A Cross-Sectional Study at a Single Academic Center.
    Cancer Causes Control. 2025;37:12.
    Abstract
    
    
60. SULTANA F, Chatterjee N, Mukherjee D, Kumar Panda C, et al
    Role of miRNAs, miR-135b-5p & miR-21-5p in metastasis of cervical cancer.
    Indian J Med Res. 2025;162:493-503.
    Abstract
    
    
61. CORREA CM, Zeferino LC, Juliato CT, Bahamondes L, et al
    Association of cervical cancer and intrauterine device use: a narrative review.
    BMC Womens Health. 2025 Dec 27. doi: 10.1186/s12905-025-04239.
    Abstract
    
    
62. LI L, Lin D, Ao K, Zhong S, et al
    YTHDF3 suppresses interferon-stimulated gene (ISG)-dependent antitumor immunity and promotes HPV carcinogenesis in cervical cancer.
    Cell Death Dis. 2025 Dec 26. doi: 10.1038/s41419-025-08188.
    Abstract
    
    
63. TODOROVA I, Panayotova Y, Kotzeva T, Greenley R, et al
    Cervical cancer in Bulgaria since EU accession in 2007: a struggle in the face of political instability.
    Health Policy. 2026;164:105497.
    Abstract
    
    
64. HOLDERNESS H, Kaufmann J, Erroba J, Marino M, et al
    Changes in breast and cervical cancer screening rates among Latinas after Medicaid expansion.
    Am J Prev Med. 2025 Dec 24:108241. doi: 10.1016/j.amepre.2025.108241.
    Abstract
    
    
65. FLANAGAN M, Fantasia HC
    A Multicomponent, Team-Based Quality Improvement Project for Improving Cervical Cancer Screenings in Primary Care.
    Nurs Womens Health. 2025 Dec 23:S1751-4851(25)00204.
    Abstract
    
    
66. KIM SK, Fontenot HB
    The Potential of Human Papillomavirus Self-Collection Testing to Improve Cervical Cancer Screening Among Women Living With HIV.
    Nurs Womens Health. 2025 Dec 23:S1751-4851(25)00211.
    Abstract
    
    
67. AKBARI P, Ali HA, Negahi M, Frimayanti N, et al
    Investigation of the effect of encapsulating cisplatin with the active compound silibinin in PLGA polymeric nanoparticles on the HeLa cervical cancer cell line.
    Med Oncol. 2025;43:79.
    Abstract
    
    
68. SHAH A, Kotadia B, Padmanaban R, Patel R, et al
    Assessing High-Risk HPV Infection Rates in Females Undergoing Cervical Cancer Screening in Western India Using HPV-DNA Testing.
    Indian J Community Med. 2025;50:933-938.
    Abstract
    
    
69. CHEN T, Zhen L, Su Y, Yi H, et al
    Nomogram for predicting urinary retention after radical hysterectomy for cervical cancer with comparative analysis of surgical methods.
    Pak J Med Sci. 2025;41:3485-3492.
    Abstract
    
    
70. GONG P, Wang H, Wang Y
    Efficacy of laparoscopic versus open abdominal radical hysterectomy on stress response and urodynamic status in patients with early cervical cancer.
    Pak J Med Sci. 2025;41:3359-3364.
    Abstract
    
    
71. PERELMUTER S, Balogun O
    The global need for brachytherapy innovation in cervical cancer.
    Brachytherapy. 2025 Dec 24:S1538-4721(25)00361.
    Abstract
    
    
72. SHI Y, Zhang Z, Di X, Shen G, et al
    Integrative analysis of single-cell and bulk transcriptomes reveals metabolic heterogeneity and identifies PFKP as a therapeutic target in cervical cancer.
    Biochim Biophys Acta Mol Basis Dis. 2025 Dec 23:168146.
    Abstract
    
    
73. SHEWALKAR BK, Pant P, Patel J, Patil A, et al
    Neoadjuvant Chemotherapy Followed by Interdigitated Brachytherapy versus Standard Chemoradiation in Locally Advanced Cervical Cancer.
    South Asian J Cancer. 2025;14:404-410.
    Abstract
    
    
74. BABU MS, Kasting ML, Rodriguez NM
    Patient attitudes toward HPV self-sampling and community health worker-delivered cervical cancer screening services in an underserved area.
    J Clin Transl Sci. 2025;9:e270.
    Abstract
    
    
75. BEN ZUR T, Gutvirtz G, Meirovitz M, Davidesko S, et al
    [Cervical Conization and the Future Risk for Preterm Labor and Cesarean Delivery].
    Harefuah. 2025;165:627-632.
    Abstract
    
    
76. EMON HH, Kowbi RN, Chowdhury MN, Teep TR, et al
    Assessing knowledge, attitudes, and barriers toward HPV cervical cancer and vaccination among female university students in Bangladesh.
    Sci Rep. 2025;15:44529.
    Abstract
    
    
77. CAI L, Luo X, Wu C, Deng X, et al
    Prognostic value of ultrasonography findings in patients with cervical cancer.
    Sci Rep. 2025;15:44471.
    Abstract
    
    
78. STRAATHOF R, Pool LI, van Vliet-Perez SM, Kolkman-Deurloo IK, et al
    Clinical factors affecting the therapeutic dose window in cervical cancer brachytherapy: A systematic review and meta-regression.
    Brachytherapy. 2025 Dec 23:S1538-4721(25)00360.
    Abstract
    
    
79. ASANO Y, Nishihara C, Kitayama T, Okawa N, et al
    MRI Images of a Case of Adenocarcinoma, Human Papillomavirus-Independent, Mesonephric Type, of the Uterine Cervix.
    Acta Med Okayama. 2025;79:463-468.
    Abstract
    
    
80. BROTHERTON JML, LaMontagne DS, Bloem PJN
    Global status of HPV vaccination two decades in: effective, safe and preventing cancer.
    Expert Rev Vaccines. 2026;25:2609869.
    Abstract
    
    
81. NAKASHIMA T, Matsumoto K, Yoshitake T, Kunitake N, et al
    Impact of high-dose pelvic radiotherapy combined with chemotherapy on local control, symptom relief, and safety in patients with stage IVB cervical cancer (FIGO 2018): a two-center retrospective study.
    Jpn J Radiol. 2025 Dec 24. doi: 10.1007/s11604-025-01923.
    Abstract
    
    
82. ZHU M, Liu J, Wang Y, Lu H, et al
    Prognostic Significance of Complete Blood Count-Derived Inflammatory Biomarkers in Patients with Small Cell Neuroendocrine Carcinoma of the Cervix.
    Curr Oncol. 2025;32:654.
    Abstract
    
    
83. PACHOLCZAK-MADEJ R, Lisik-Habib M, Madry R, Szarszewska M, et al
    Real-world outcomes of immune checkpoint inhibitor monotherapy in later lines of recurrent/metastatic cervical cancer - evidence from a rescue access program in Poland.
    Contemp Oncol (Pozn). 2025;29:384-392.
    Abstract
    
    
84. LIU Z, Zhang S, Wang Y, Zong Y, et al
    Development and validation of immunotherapy nomogram for predicting the efficacy and prognosis of recurrent and metastatic cervical cancer.
    Front Immunol. 2025;16:1662605.
    Abstract
    
    
85. ZHOU D, Wang R, Huang L, Yan P, et al
    Real-world efficacy assessment for sintilimab in recurrent or metastatic cervical cancer.
    PeerJ. 2025;13:e20477.
    Abstract
    
    
86. HE Q, Xiao L, Lan Y, Yao D, et al
    Analysis of the Development Trajectory and Influencing Factors of Depression in Patients With Cervical Cancer During Concurrent Chemoradiotherapy.
    Actas Esp Psiquiatr. 2025;53:1366-1374.
    Abstract
    
    
87. FUJISAKI M, Matsumoto K
    [Latest Drug Therapies for Cervical Cancer].
    Gan To Kagaku Ryoho. 2025;52:858-863.
    Abstract
    
    
88. SHAN H, Xu Q
    Prognostic significance of pretreatment systemic immune-inflammation index (SII) in patients with cervical cancer: a meta-analysis.
    World J Surg Oncol. 2025 Dec 23. doi: 10.1186/s12957-025-04167.
    Abstract
    
    
89. CHOPRA S, Samanta A, Nagar A, Mittal P, et al
    Is single implant and multiple fractions radio-biologically iso-effective for cervical cancer high-dose-rate brachytherapy: Observation from patient cohorts during COVID pandemic.
    Brachytherapy. 2025 Dec 22:S1538-4721(25)00365.
    Abstract
    
    
90. YOSHIDA-COURT K, Teka B, Cisneros Napravnik T, Karpinets T, et al
    Linking Microbiome Diversity and Immune Profiles in Ethiopian Patients With Cervical Cancer.
    JCO Glob Oncol. 2025;11:e2500060.
    Abstract
    
    
91. HUANG Q, Wang F, Li X, Zou W, et al
    Multi-omics profiling reveals an immunosuppressive plasma cell subset within tertiary lymphoid structures in cervical cancer.
    Cancer Immunol Immunother. 2025;75:26.
    Abstract
    
    
92. KUMAR P, Ray A, Hora R, Kumari A, et al
    Social Determinants of Human Papillomavirus Vaccine Uptake Among Adolescent Girls in Low-Middle-Income Countries: A Systematic Review & Meta-Analysis.
    Inquiry. 2025;62:469580251399368.
    Abstract
    
    
93. SUJAY PS, Balaji R
    GC-MS and in silico analysis reveal astaxanthin, nimbin, and gamma-sitosterol from Nyctanthes arbor-tristis flowers as dual modulators of HPV E6 and p53 in cervical cancer.
    In Silico Pharmacol. 2025;14:9.
    Abstract
    
    
94. NAVA M, Earl J, Patel H, Canizares M, et al
    Cancer Disparities and the Political Economy of Healthcare Access: A County-Level Analysis in a High-Disparity County.
    J Prim Care Community Health. 2025;16:21501319251406402.
    Abstract
    
    
95. PAN M, Yi T, Lei P, Mo J, et al
    Identification of Glutathione Synthetase as a Therapeutic Target for Cervical Cancer via Combining Bioinformatics and Experimental Validation.
    J Cell Mol Med. 2025;29:e70968.
    Abstract
    
    
96. WU X, Wang B, Liu L, Chen Z, et al
    Multi-omics analysis reveals that knockdown of IMPA2 induces apoptosis in cervical cancer cells through ROS/MYC/CDK1 signaling.
    Clin Transl Oncol. 2025 Dec 22. doi: 10.1007/s12094-025-04167.
    Abstract
    
    
97. CHEN G, Zhang W, HuYan Y, Yang Y, et al
    Application value of TPAS staining technique for cervical exfoliated cells in cervical cancer screening.
    Diagn Pathol. 2025 Dec 22. doi: 10.1186/s13000-025-01744.
    Abstract
    
    
98. MIDAKSA M, Destaw A, Getachew S, Tamrat D, et al
    Health system challenges in the diagnostic and treatment pathway for patients with suspected cervical cancer: a qualitative study.
    BMC Health Serv Res. 2025 Dec 22. doi: 10.1186/s12913-025-13918.
    Abstract
    
    
99. ZHANG L, Yang Q, Zhu H, Zheng Z, et al
    Cadonilimab plus chemotherapy compared to chemotherapy as first-line treatment for persistent, recurrent, or metastatic cervical cancer in China: a cost-effectiveness analysis.
    BMC Health Serv Res. 2025 Dec 22. doi: 10.1186/s12913-025-13871.
    Abstract
    
    
100. MANDIWA C, Sanna M, Gao W
     Association between mass media exposure and cervical cancer screening uptake among women aged 30-49 years in four sub-Saharan African countries: a pooled analysis of demographic and health surveys.
     BMC Womens Health. 2025;25:603.
     Abstract
     
     
101. ZHANG L, Fan X, Ma J, Zhang J, et al
     Distinct immune cell dynamics associated with immune-related adverse events during combined chemoradiation and immune checkpoint inhibitor therapy.
     Nat Commun. 2025;16:11565.
     Abstract
     
     
102. WANG J, Liu S, Li P, Negrin YP, et al
     Unveiling the ZNF384-INTS13-hnRNPC axis as a therapeutic vulnerability in cervical cancer.
     Cell Death Dis. 2025;16:920.
     Abstract
     
     
103. WANG W, Yang G, Liu Y, Wei L, et al
     Author Correction: Multimodal deep learning model for prognostic prediction in cervical cancer receiving definitive radiotherapy: a multi-center study.
     NPJ Digit Med. 2025;8:774.
     Abstract
     
     
104. KIRUBA B, Raja Karthikeyan RRR, Anilkumar SR, Sundararajan V, et al
     Implications of Single-Cell RNA Sequencing in Cervical Cancer: Unravelling the Molecular Landscape.
     ACS Omega. 2025;10:60080-60093.
     Abstract
     
     
105. HUANG C, Qiu Y, Huang X, Tang H, et al
     A digital health intervention: development and validation of a social media nursing program for sexual dysfunction following cervical cancer radical hysterectomy.
     Front Public Health. 2025;13:1720263.
     Abstract
     
     
106. MONDAL J, Chatterjee R, Kumar Gourisaria M, Sahni M, et al
     Cervical cancer classification using a novel hybrid approach.
     Front Oncol. 2025;15:1703772.
     Abstract
     
     
107. YAN HY, Shen XP, Tao PP, Jin L, et al
     Deep learning models for cervical cancer subtyping using whole slide images.
     Front Oncol. 2025;15:1574639.
     Abstract
     
     
108. 
     Retraction: MicroRNA-92a Promotes Cell Proliferation in Cervical Cancer via Inhibiting p21 Expression and Promoting Cell Cycle Progression.
     Oncol Res. 2025;33:4157.
     Abstract
     
     
109. HE G, Huang Y, Zhang X, Yuan L, et al
     Landscape Analysis of Human Papillomavirus (HPV) Prophylactic Vaccine Clinical Trials in China Based on the NMPA Database.
     Drug Des Devel Ther. 2025;19:11245-11257.
     Abstract
     
     
110. CRABB K, Okwesa J, Yap JKW, Kwong FL, et al
     Challenges in managing cervical cancer in pregnancy: Three case reports.
     Case Rep Womens Health. 2025;48:e00765.
     Abstract
     
     
111. DEWAN SMR, Proma AY, Khan SA, Meem SS, et al
     Evaluation of the Association of TNF-alpha rs361525 Gene Polymorphism in Bangladeshi Patients With Breast and Cervical Cancer: A Case-Control Study and Meta-Analysis.
     Health Sci Rep. 2025;8:e71653.
     Abstract
     
     
112. BERKEL C
     Radiotherapy or chemoradiotherapy might sensitize cervical cancer cells to plasma membrane rupture during necroptosis by upregulating the expression of SIGLEC12, a recently identified membrane-rupturing protein.
     Hum Cell. 2025;39:24.
     Abstract
     
     
113. OZBAS S, Gerey S, Koc SO
     Attitudes Towards Early Diagnosis of Cervical Cancer Among Women Applying to a Health Institution in Turkey.
     J Obstet Gynaecol Res. 2025;51:e70174.
     Abstract
     
     
114. SORMANI J, Moukam A, Wisniak A, Yakam V, et al
     Psychological and sexual impact of human papillomavirus screening in women in Cameroon: a prospective cohort study.
     BMC Womens Health. 2025;25:602.
     Abstract
     
     
115. PEREIRA D, Almeida AM, Queiroz JA, Sousa F, et al
     Innovative minicircle DNA vector encoding pri-miR-375 silences E6 and E7 oncoproteins in HPV16-positive CaSki cells.
     Gene. 2026;981:149964.
     Abstract
     
     
116. DHUSIYA HR, Sethy P, Pati S, Pradhan SK, et al
     How can the uptake of HPV vaccination be increased in school going girls? a qualitative study with multiple stakeholders in Ganjam, Odisha.
     Int J Adolesc Med Health. 2025;37:421-430.
     Abstract
     
     
117. PANG D, Zhang S, Yang H, Liang K, et al
     (18)F-FDG PET radiomics for predicting progression-free survival in locally advanced cervical squamous cell carcinoma.
     Hell J Nucl Med. 2025;28:232-245.
     Abstract
     
     
118. PEREZ BIANCHI P, Anselmo S, Vasquez Currie M, Medel J, et al
     RIVA: An Image Dataset of Conventional Pap Smear Cytology with Multiple Independent Annotations.
     Sci Data. 2025;12:1991.
     Abstract
     
     
119. CHEN X, Wang S, Ding B, Nie Y, et al
     Dibutyl phthalate (DBP) induces cervical injury and promotes malignant transformation of cervical epithelial cells.
     Food Chem Toxicol. 2026;208:115885.
     Abstract
     
     
120. IKEMOTO A, Uchiyama T, Takeda M, Nakamine H, et al
     Spindle-cell variant of diffuse large B-cell lymphoma in the uterine cervix: a case report and literature review.
     J Clin Exp Hematop. 2025;65:312-317.
     Abstract
     
     
121. MOHAMMADI M, Fell C, Morrison D, Bell S, et al
     Cervical whole-slide images dataset for multiclass classification.
     Gigascience. 2025;14:giaf144.
     Abstract
     
     
122. ZHU L, Wu Z, Shi S, Xue H, et al
     Dysbiosis of vaginal and peritoneal fluid microbiota in patients with cervical lesions.
     BMC Womens Health. 2025;25:631.
     Abstract
     
     
123. FEREDE KG, Bantie B, Abdu AM, Ferede AG, et al
     Prevalence and predictors of cervical lesions among women on ART in the Awi Zone, Northwest Ethiopia: facility-based cross-sectional study.
     BMC Womens Health. 2025;25:622.
     Abstract
     
     
124. ESCOBAR V, Catalan A, Callejas V, Araya R, et al
     Human papillomavirus (HPV) genotypes extended prevalence in the female population from a city in Northern Chile.
     BMC Womens Health. 2025;25:617.
     Abstract
     
     
125. CHEN M, Wu Y, Wang L, Li L, et al
     A non-inferiority study of 5-aminolevulinic acid photodynamic therapy (5-ALA-PDT) for high-grade squamous intraepithelial lesions of the cervix in patients of childbearing age: A non-randomized controlled prospective study.
     Photodiagnosis Photodyn Ther. 2025;56:105280.
     Abstract
     
     
126. BANNOUR I, Mastouri S, Bannour R, Saoudi R, et al
     HPV vaccination: analysis of acceptability among mothers - a study of 160 cases.
     Int J Adolesc Med Health. 2025;37:389-396.
     Abstract
     
     
127. CHEN M, Li H, Wang L, Li L, et al
     Comparison of the efficacy of photodynamic therapy alone and photodynamic therapy after laser pretreatment for high-grade cervical intraepithelial lesions in women of childbearing age: a prospective study.
     Photodiagnosis Photodyn Ther. 2025;56:105260.
     Abstract
     
     
128. SUN B, Chen Y, Cao D, Xu Y, et al
     Evaluation of the efficacy of carbon dioxide laser combined with 5-aminolevulinic acid photodynamic therapy in treating high-grade vaginal squamous intraepithelial lesions following hysterectomy.
     Photodiagnosis Photodyn Ther. 2025;56:105256.
     Abstract
     
     
129. WANG X, Chen Y, Xu X, Huang J, et al
     Evaluation of the efficacy of topical photodynamic therapy against cervical HPV infection.
     Photodiagnosis Photodyn Ther. 2025;56:105250.
     Abstract
     
     
130. YUAN S, Zhang M, Zhang C, Su Y, et al
     Effect of topical photodynamic therapy with 5-aminolevulinic acid in the treatment of high-risk cervical low-grade squamous intraepithelial lesions.
     Photodiagnosis Photodyn Ther. 2025;56:105248.
     Abstract
     
     
131. SIERRA MS, Coto C, Porras C, Herrero R, et al
     Validation of TypeSeq2, a Next-Generation-Based Sequencing Assay for the Detection of 46 Human Papillomavirus Genotypes, at the US National Cancer Institute and Costa Rica Laboratories.
     J Infect Dis. 2025;232:e906-e915.
     Abstract
     
     
132. HETLAND FALKENTHAL TE, Nygard S, Nygard M
     Beyond Women's Health: Long-Term HPV-related Cancer Trends in Norway.
     J Infect Dis. 2025 Jul 9:jiaf351. doi: 10.1093.
     Abstract
     
     
133. CHEN M, Guo J, Xu B
     Targeted Fluorescent Polysaccharide Platform for Solute Carrier Protein PCNA Detection and Cervical Squamous Cell Carcinoma Inhibition.
     J Fluoresc. 2025;35:11539-11552.
     Abstract
     
     
134. CHENG E, Stubbs JM, Achat HM
     Self-Collection for HPV-Based Cervical Screening: Knowledge and Attitudes of Australian Health Care Workers in an Area With Low Screening Rates, July-November 2023.
     Public Health Rep. 2026;141:43-50.
     Abstract
     
     
135. KESZTHELYI M, Sziva RE, Havran Z, Szabo V, et al
     Systemic Inflammatory Indices-Systemic Immune-Inflammation Index (SII) and the Systemic Inflammation Response Index (SIRI)-As Potential Rule-Out Biomarkers for Invasive Cervical Carcinoma.
     Int J Mol Sci. 2025;27:435.
     Abstract
     
     
136. ALVARADO-CAMACHO DA, Castillo-Velazquez R, Granados-Lopez AJ, Hernandez-Lopez H, et al
     Differentially Expressed Genes Associated with the Development of Cervical Cancer.
     Int J Mol Sci. 2025;27:258.
     Abstract
     
     
137. WANG M, Cao Y, Zhang W, Liang Y, et al
     Prediction Model of Lymph Node Metastasis in Cervical Cancer Based on MRI Habitat Radiomics.
     Cancers (Basel). 2025;18:152.
     Abstract
     
     
138. GORECKI G, Hale M, Taylor S, Garcia G, et al
     Prognostic Value of Lymphoid Infiltration and Aggregation in Cervical Cancer.
     Cancers (Basel). 2025;18:129.
     Abstract
     
     
139. SEMINARIO N, Bebia V, Luzarraga Aznar A, Jose MS, et al
     Postvoid Residual Volume After Radical Hysterectomy for Early-Stage Cervical Cancer: Predictive Factors and a Decision-Making Algorithm.
     Cancers (Basel). 2025;18:24.
     Abstract
     
     
140. FAN C, Fu C
     Cross-country inequalities and frontier analysis in global burden of cervical cancer: cross-sectional studies.
     J Gynecol Oncol. 2026 Dec 18. doi: 10.3802/jgo.2026.
     Abstract
     
     
141. WANG S, Zhu Q, Lu Y, Yang X, et al
     Update of incidence and survival in patients with cervical cancer in the United States from 2000 to 2021.
     J Gynecol Oncol. 2026 Dec 18. doi: 10.3802/jgo.2026.
     Abstract
     
     
142. LOVKIEL A, Petersen LK
     Increasing cervical cancer screening participation: a cluster-randomized pilot study at a department of gynaecology.
     BMC Womens Health. 2026 Jan 9. doi: 10.1186/s12905-025-04250.
     Abstract
     
     
143. WANG L, Li X, Ren C, Liu L, et al
     Site-specific HPV18 integration facilitates cervical carcinogenesis through metabolic reprogramming-induced dysfunction of the SpHK1/S1P/S1PR1 pathway.
     Cell Death Dis. 2026;17:24.
     Abstract
     
     
144. LAN C, Zhang P, Zhao J, Li Q, et al
     Spatiotemporal Immune Determinants of Response to Immune Rechallenge in Advanced Cervical Cancer.
     Cancer Discov. 2026 Jan 9. doi: 10.1158/2159-8290.CD-25-0467.
     Abstract
     
     
145. DA SILVA LOUZA LG, de Sousa Gomes ML, Oria MOB, Rafael EV, et al
     Applicability of the levels of the socio-ecological model in the context of cervical cancer prevention: a scoping review.
     Cancer Causes Control. 2026;37:16.
     Abstract
     
     
146. LIU J, Lei L, Liu Y, Wu J, et al
     Tanshinone I Promotes Ferroptosis of Cervical Cancer Cells by Activating the ATF3-Mediated Transcriptional Inhibition of FSP1.
     Appl Biochem Biotechnol. 2026 Jan 9. doi: 10.1007/s12010-025-05535.
     Abstract
     
     
147. WANG K, Si L, Zhao M, Guo R, et al
     Preoperative assessment of tumor size by MRI and ultrasound in cervical cancer: a large-scale retrospective comparative study.
     Arch Gynecol Obstet. 2026;313:23.
     Abstract
     
     
148. ZHANG L, Mwita CJ, Soliman GA, Mushi DF, et al
     Nutritional Status of Patients Diagnosed with Cervical Cancer in Tanzania.
     Res Sq [Preprint]. 2025 Dec 18:rs.3.rs-7780798. doi: 10.21203/rs.3.rs-7780798.
     Abstract
     
     
149. ZHANG LL, Ji YF, Li J, Wang WH, et al
     Construction of a prognostic model based on efferocytosis for predicting survival and immunotherapy efficacy in cervical cancer.
     Transl Cancer Res. 2025;14:8908-8929.
     Abstract
     
     
150. PAI N, Rao JS
     Data-based clustering in prediction of cervical cancer DNA methylation using pan-cancer genetic and clinical data.
     Bioinform Adv. 2025;6:vbaf316.
     Abstract
     
     
151. BEREZA K, Banas T, Grabarek BO, Czerw A, et al
     Levels of Systemic Inflammatory Markers in Women with Cervical Cancer Undergoing Definitive Chemoradiotherapy Depend Primarily on Pre-treatment and Post-teletherapy Tumor Volume, Rather than on the Prescribed Radiation Dose.
     Curr Pharm Biotechnol. 2026 Jan 6. doi: 10.2174/0113892010413911251122074226.
     Abstract
     
     
152. XIN W, Zhang J, Wu D, Cai Y, et al
     VAMP7-mediated autophagy regulates cervical cancer progression associated with persistent HPV16 infection.
     Clin Transl Med. 2026;16:e70590.
     Abstract
     
     
153. OYARO B, Wanje G, Richardson BA, Temmerman M, et al
     A mixed-methods assessment of individual client-level and clinic-level factors associated with uptake of cervical cancer screening (CCS) services in family planning (FP) clinics receiving an intervention to support these services in Mombasa County, Ke
     Implement Sci Commun. 2026 Jan 9. doi: 10.1186/s43058-025-00852.
     Abstract
     
     
154. ZONG Y, Zhang D, Li Y, Wang P, et al
     Rare early-onset radiation-induced lumbosacral plexopathy in cervical cancer: a case report.
     BMC Neurol. 2026 Jan 8. doi: 10.1186/s12883-025-04601.
     Abstract
     
     
155. LI F, Wei Z, Tao M, Zhao K, et al
     Notch1(+) cervical cancer cells may promote perineural invasion by secreting neurotrophin-4.
     Sci Rep. 2026 Jan 8. doi: 10.1038/s41598-025-34812.
     Abstract
     
     
156. FAN QQ, Qin HF, Liu YQ
     Artemisinin Inhibits Drug Resistance and Epithelial-Mesenchymal Transition in Cervical Cancer Cells via the Wnt/beta-Catenin Signaling Pathway.
     Bull Exp Biol Med. 2026 Jan 8. doi: 10.1007/s10517-026-06540.
     Abstract
     
     
157. ZHANG R, Chai S, Zhang F, Lai J, et al
     Hypoxia promotes progression of cervical cancer by modulating the ATXN3-enhanced P53 stability or STAT5 phosphorylation.
     Cell Death Discov. 2026;12:4.
     Abstract
     
     
158. PEPPA V, Robitaille M, Akbari F, Enger SA, et al
     Clinical test cases for commissioning, QA, and benchmarking of model-based dose calculation algorithms in (1)(9)(2)Ir HDR gynecologic tandem and ring brachytherapy.
     Med Phys. 2026;53:e70260.
     Abstract
     
     
159. OSHIKANLU BC, Sowunmi AC, Habeebu MY, Dada AO, et al
     Serum Squamous Cell Carcinoma Markers: A Case-Control Study for Cervical Cancer.
     Clin Med Res. 2025;23:129-136.
     Abstract
     
     
160. FANG H, Mu J, Chow EP, Ong JJ, et al
     Chinese caregivers' preferences and predicted uptake of HPV vaccination: a study protocol for two discrete choice experiments.
     BMJ Open. 2026;16:e089565.
     Abstract
     
     
161. VAN LONKHUIJZEN L, Mom CH, van der Aa M
     Cervical cancer in women eligible for HPV-vaccination in the Netherlands.
     J Gynecol Obstet Hum Reprod. 2026 Jan 6:103107. doi: 10.1016/j.jogoh.2026.103107
     Abstract
     
     
162. SEEMAAB A, Colaizzi A, Matsko J, Ye Y, et al
     Assessment of microorganism detection in ThinPrep Papanicolaou tests utilizing the Hologic Genius Digital Diagnostics System.
     Am J Clin Pathol. 2025;164:946-952.
     Abstract
     
     
163. GANGULY AP, Pretsch PK, Brewer NT, Spees LP, et al
     Streamlined Self-Collection Screening for Sexually Transmitted Infections and Human Papillomavirus: A Single-Group Secondary Analysis of a Randomized Clinical Trial.
     JAMA Netw Open. 2026;9:e2551345.
     Abstract
     
     
164. KITAMI K, Kuji S, Kamiya N, Machida H, et al
     Real-world safety and efficacy of immune checkpoint inhibitors in Japanese patients with persistent, recurrent, or metastatic cervical cancer: a multicenter prospective and retrospective study.
     Int J Clin Oncol. 2026 Jan 8. doi: 10.1007/s10147-025-02951.
     Abstract
     
     
165. MURUGAIYAN K, Srivastava R, Balaraman J, Eswar K, et al
     Gold-Coated Glybosomes Mimicking Physiological Micelles for ROS-Mediated Photothermal Ablation against Cervical Cancer.
     ACS Appl Bio Mater. 2026 Jan 8. doi: 10.1021/acsabm.5c02289.
     Abstract
     
     
166. OLTHOF EP, Oostveen NA, van der Aa MA, Bekkers RLM, et al
     Prognostic and therapeutic implications of clinical-radiologic discrepancy in parametrial invasion prior to primary radical hysterectomy in cervical cancer.
     Gynecol Oncol Rep. 2025;63:102002.
     Abstract
     
     
167. JURJUT O, Weiss M, Daniel Y, Matovina S, et al
     Detection of Cervical Intraepithelial Neoplasia Using Hyperspectral Tissue Signatures.
     IEEE J Transl Eng Health Med. 2025;13:532-539.
     Abstract
     
     
168. SINNO AK, Mustapha A, Nair N, Zaami S, et al
     Circulating Tumor DNA in Cervical Cancer: Clinical Utility and Medico-Legal Perspectives.
     Oncol Res. 2025;34:4.
     Abstract
     
     
169. JIANG C, Rosenberg PS, Jemal A, Sung H, et al
     Cervical cancer incidence rates by birth cohort against the backdrop of human papillomavirus vaccination in the United States.
     J Natl Cancer Inst. 2026 Jan 7:djaf374. doi: 10.1093.
     Abstract
     
     
170. LU R, Zhang J, Ma X, Feng Y, et al
     Dual-dimensional profiling of host genomic variations and HPV integration in PD-L1-stratified cervical cancer via Oxford Nanopore Technology.
     J Transl Med. 2026 Jan 7. doi: 10.1186/s12967-025-07674.
     Abstract
     
     
171. PATEL MS, Patel KS, Willmann J, Feliciano EJG, et al
     Cervical cancer screening beyond traditional barriers.
     Lancet Public Health. 2026;11:e6.
     Abstract
     
     
172. MEGLIC E, Ploner A, Clements M, Elfstrom M, et al
     Herd effect of human papillomavirus vaccination on incidence of high-grade cervical lesions: a population-based cohort study in Sweden.
     Lancet Public Health. 2026;11:e35-e43.
     Abstract
     
     
173. LI H, Ahmad M, Zhou D
     Relaxin-2 Inhibits Cervical Cancer Growth by Downregulating Kruppel-Like Factor 5 (KLF5) Through the Inhibition of Hippo-YAP and JAK2/STAT3 Signaling Pathways.
     J Biochem Mol Toxicol. 2026;40:e70687.
     Abstract
     
     
174. KABIR SF, Ashik-Ur-Rahman M, Rahman A, Hossen MA, et al
     Factors Associated With Low Utilization of Cervical Cancer Screening Services in Gazipur, Bangladesh.
     Obstet Gynecol Int. 2025;2025:4476955.
     Abstract
     
     
175. ROMANOVA M, Klat J
     Prognostic significance of L1CAM in cervical cancer: A narrative review.
     Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2026.
     Abstract
     
     
176. SOLTAU CP, Sinha D, Patil LP, Moseley PM, et al
     Redox-active nitroxides enhance cisplatin efficacy against cervical cancer.
     Redox Biol. 2025;89:103989.
     Abstract
     
     
177. YUAN K, Bai Y, Chen S, Shi Y, et al
     The effects of earthworm fibrinolytic enzyme on cervical cancer Caski cells based on CiteSpace and VOSviewer visual analysis.
     Medicine (Baltimore). 2026;105:e46783.
     Abstract
     
     
178. ZHAI J, Pang T, An Y, Wang J, et al
     Clinical significance of CXCL17 in cervical cancer.
     Medicine (Baltimore). 2026;105:e46178.
     Abstract
     
     
179. HERNANDEZ A, Burrowes S, Gelaw B, Abede T, et al
     Is there a difference in sample adequacy when vaginal HPV DNA samples are self-collected at home, a health post, or a primary care health center in rural Ethiopia? Implications for community cervical cancer screening.
     BMC Womens Health. 2026 Jan 7. doi: 10.1186/s12905-025-04226.
     Abstract
     
     
180. ALHMEID EK, Aldohni AAA, Alghanim AI, Salha RM, et al
     Sociodemographic Determinants of Cervical Cancer Screening among Ever-Married Women in Jordan: Insights from the 2023 Jordan Population and Family Health Survey.
     J Epidemiol Glob Health. 2026;16:5.
     Abstract
     
     
181. LIU R, Liang L, Wang J, Wang M, et al
     Optimization of Liquid-Based Cytology Block Preparation Using Modified Adhesive Centrifugal Sedimentation for Improved Diagnostic Accuracy in Cervical Lesions.
     APMIS. 2026;134:e70131.
     Abstract
     
     
182. NANDAKUMAR V, Krishnan S, Chang CP, Yee S, et al
     High-risk human papillomavirus genotype prevalence in Singapore cervical samples: Implications for clinical management.
     Ann Acad Med Singap. 2025;54:758-765.
     Abstract
     
     
183. SURMAVA S, Kvaratskhelia E, Davitashvili B, Vardiashvili N, et al
     Exploratory Analysis of Candidate Gene SNPs in Relation to Cervical Cancer Susceptibility in Georgian Women.
     Cancer Control. 2026;33:10732748251413338.
     Abstract
     
     
184. MA LL, Yang SJ
     [Mucosal melanoma with atypical EWSR1 break-apart signal arising in the cervix and vagina: report of a case].
     Zhonghua Bing Li Xue Za Zhi. 2026;55:93-95.
     Abstract
     
     
185. CHRISTINE B, Bush M, Thurakal A, Sheehy AM, et al
     New Cervical Cancer Screening Guidelines From the US Department of Health and Human Services: Strengthening Women's Preventive Health.
     JAMA. 2026 Jan 5. doi: 10.1001/jama.2025.26456.
     Abstract
     
     
186. PENG D, Zhang A, Zhang Y
     Bridging digital divides: A quantitative assessment of equity, access, and determinants of AI adoption for women's reproductive cancer care in China.
     Afr J Reprod Health. 2025;29.
     Abstract
     
     
187. YUAN H, Wang X, Liu K, Zhang J, et al
     Immune Checkpoint-Related Gene Polymorphisms and High Serum Concentration of PD-L1 and CTLA4 Contribute to the Resistance to Platinum-Based Chemotherapy in Cervical Cancer.
     Int J Womens Health. 2025;17:5719-5731.
     Abstract
     
     
188. QIAN XF, Wang XW, Yi HQ, Li LF, et al
     Peritoneal Post-Radiation Angiosarcoma in a Patient With a History of Radiation for Cervical Cancer.
     Am J Case Rep. 2026;27:e949701.
     Abstract
     
     
189. GONG Y, Wu J, Hu Y
     m(6)A epitranscriptomic regulation of KRAS by METTL3 promotes EMT and stromal remodeling through TGF-beta/SMAD signaling in cervical cancer.
     Cancer Gene Ther. 2026 Jan 3. doi: 10.1038/s41417-025-00993.
     Abstract
     
     
190. LIU X, Guo L, Zhang H, Xue L, et al
     Multi-omics profiling reveals that targeting NEK3 synergizes with cuproptosis to promote M1 macrophage polarization in cervical cancer.
     Int Immunopharmacol. 2026;171:116128.
     Abstract
     
     
191. SABEENA S, Beynon C
     The Impact of the COVID-19 Pandemic on HPV Vaccination Coverage Among Adolescents From High-Income Countries and Challenges: A Scoping Review.
     Rev Med Virol. 2026;36:e70102.
     Abstract
     
     
192. WU Y, Wei B, Wei Z, Wang H, et al
     Single-cell and spatial transcriptomic profiling reveals distinct tumor microenvironment dynamics in cervical adenocarcinoma and squamous cell carcinoma.
     Commun Biol. 2025;9:46.
     Abstract
     
     
193. CHATTERJEE R
     Sexual assault and cancer pathways: a scoping review of biomedical and screening outcomes.
     BMC Womens Health. 2025;26:16.
     Abstract
     
     
194. ABUDUREXITI G, Muhetaer K, Yang J, Zhuo Q, et al
     HPV vaccine knowledge gaps and vaccination intent: a cross-sectional study of vocational students in Southern Xinjiang of China in 2023.
     BMC Public Health. 2025;26:102.
     Abstract
     
     
195. CALFA S, de Freitas AJA, Causin RL, Hirai W, et al
     Exploring shared microRNA profiles in liquid-based cytology and plasma as biomarkers of high-grade intraepithelial lesions.
     Sci Rep. 2025;16:828.
     Abstract
     
     
196. GETIE B, Wondimu E, Almaw A, Legese B, et al
     Prevalence and risk factors of high-risk cervical HPV infections among women attending Debre Tabor hospital family planning and gynecology clinic, Northcentral Ethiopia.
     Sci Rep. 2025;16:779.
     Abstract
     
     
197. LAM MCY, Mbogo BW, Plaunt E, Mukankaka S, et al
     Transport stipend to facilitate cancer early detection: experiences of beneficiaries and perspectives of program personnel in Rwanda.
     BMC Public Health. 2025;26:13.
     Abstract
     
     
198. ALIZADEH L, Keshavarz Z, Shalbaf A, Iranpour S, et al
     Iranian women's perceptions of human papillomavirus and barriers to vaccination: a qualitative study based on the health belief model.
     BMC Public Health. 2025;26:5.
     Abstract
     
     
199. LIU Y, Han Z, Kaminski P, Tao C, et al
     Topoisomerase IIalpha orchestrates secretion of IL-6 and IL-8 with human papillomavirus replication.
     Virol Sin. 2025;40:946-961.
     Abstract
     
     
200. KHASTGIR G, Saha PK, Bagga R
     From hesitancy to hope: charting India's path to widespread HPV immunisation.
     Eur J Contracept Reprod Health Care. 2026;31:53-58.
     Abstract
     
     
201. BROSHKEVITCH CJ, Pretsch PK, Spees LP, Wheeler SB, et al
     Underscreened Women's Reactions to At-Home Self-Collected Human Papillomavirus Test Result Delivery.
     Sex Transm Dis. 2026;53:109-115.
     Abstract
     
     
202. KOBAYASHI M, Nakagawa S, Ishii Y, Kamei Y, et al
     VRK1 Is a Novel Therapeutic Target for Small Cell Neuroendocrine Carcinoma of the Cervix.
     Cancer Sci. 2026;117:78-89.
     Abstract
     
     
203. EBNER C, Purtscheller R, Feroz B, Rieker J, et al
     Biopsy-proven residual cervical cancer at the end of combined chemoradiation predicts poor outcome-Retrospective single-center cohort study.
     Acta Obstet Gynecol Scand. 2025 Dec 21. doi: 10.1111/aogs.70106.
     Abstract
     
     
204. KNUDSEN AS, Randrup TH, Kesmodel US, Booth BB, et al
     Negative margins and negative HPV tests after large loop excision of the transformation zone: A nationwide historical cohort study.
     Acta Obstet Gynecol Scand. 2026;105:186-194.
     Abstract
     
     
205. WANG M, Fan J, Mu B, Zeng Y, et al
     HDAC5 stabilization by tubeimoside I suppresses cervical cancer metastasis via inhibiting H3K27ac/KPNA2 axis.
     Br J Cancer. 2026 Jan 8. doi: 10.1038/s41416-025-03328.
     Abstract
     
     
206. TERZIOGLU HG, Aragao A, Barroeta JE
     "Atypical Glandular Cells" on Cervical Cytology: Correlation Between Glandular Cell Component Volume and Histological Follow-Up.
     Diagn Cytopathol. 2026;54:71-77.
     Abstract
     
     
207. TANG W, Wang L, Li X, Yan X, et al
     Radiation-induced acquired expression of PD-L1 and reprogramming of the tumor microenvironment in cervical cancer.
     Gynecol Oncol. 2026;205:17-26.
     Abstract
     
     
208. PALMER TJ, Kavanagh K, Cuschieri K, Cameron RL, et al
     Sustained impact of bivalent HPV immunisation on CIN incidence over two rounds of cervical screening.
     Int J Cancer. 2025 Nov 3. doi: 10.1002/ijc.70183.
     Abstract
     
     
209. KALJOUW S, Jansen EEL, Olthof EMG, Hontelez JAC, et al
     Under which realistic circumstances is hrHPV self-sampling increasing cervical screening effectiveness in a partly vaccinated population? A modelling study.
     Int J Cancer. 2026;158:1361-1369.
     Abstract
     
     
210. IMARENGIAYE EO, Iweka RO, Anya CJ, Nwaogwugwu JC, et al
     Knowledge, acceptance, uptake barriers and missed opportunities of human papillomavirus vaccine among female adolescents in Benin City, Nigeria: A mixed method study.
     Int J Gynaecol Obstet. 2026;172:373-382.
     Abstract
     
     
211. PERALTA J, Rodriguez J, Acosta JA, Nunez M, et al
     Management of invasive cervical carcinoma in three oncology centers in Latin America: A historical cohort study.
     Int J Gynaecol Obstet. 2025 Jul 17. doi: 10.1002/ijgo.70371.
     Abstract
     
     
212. KARATAS E, Salman MC, Basaran D, Akgor U, et al
     Predictors of lymphocyst development following lymphadenectomy in patients with gynecologic cancer.
     Int J Gynaecol Obstet. 2025 Jul 17. doi: 10.1002/ijgo.70377.
     Abstract
     
     
213. LI M, Xu S, Yang Q, Zheng Z, et al
     Epidemiological trends of gynecologic cancer burden in east Asian countries from 1990 to 2021 and projections to 2031.
     Int J Gynaecol Obstet. 2025 Jul 4. doi: 10.1002/ijgo.70351.
     Abstract
     
     
214. MATSUO K, Matsuzaki S, Roman LD
     Response to "Correspondence on 'Identifying the possible candidate population for adjuvant radiotherapy de-escalation for intermediate-risk cervical cancer' by Matsuo et al" by Hu Y and Fang Q.
     Int J Gynecol Cancer. 2025 Dec 5:102840. doi: 10.1016/j.ijgc.2025.102840.
     Abstract
     
     
215. XU Q, Han J
     Correspondence on "Diagnostic performance of ultrasound-guided biopsy for detecting recurrent or persistent cervical cancer after chemoradiotherapy: a prospective, single-center study" by Mascilini et al.
     Int J Gynecol Cancer. 2025 Dec 5:102846. doi: 10.1016/j.ijgc.2025.102846.
     Abstract
     
     
216. SONG Y, Ran G, Zeng R, Chen C, et al
     Global burden and temporal trends of cervical cancer in women aged 60 years and older, 1990-2021: a Global Burden of Disease study.
     Int J Gynecol Cancer. 2025;36:102851.
     Abstract
     
     
217. HU Y, Fang Q
     Correspondence on "Identifying the possible candidate population for adjuvant radiotherapy de-escalation for intermediate-risk cervical cancer" by Matsuo et al.
     Int J Gynecol Cancer. 2025 Nov 26:102831. doi: 10.1016/j.ijgc.2025.102831.
     Abstract
     
     
218. WANG K, Zhai Q, Xie Y, Tian Y, et al
     Sentinel node mapping with carbon nanoparticles versus lymphadenectomy in early cervical cancer.
     Int J Gynecol Cancer. 2025;36:102881.
     Abstract
     
     
219. CIANCIA M, Mascilini F, Moro F, Testa AC, et al
     Response to the Correspondence by Xu et al. on "Diagnostic performance of ultrasound-guided biopsy for detecting recurrent or persistent cervical cancer after chemoradiotherapy: a prospective, single-center study" by Mascilini et al.
     Int J Gynecol Cancer. 2025 Dec 18:102882. doi: 10.1016/j.ijgc.2025.102882.
     Abstract
     
     
220. WU Q, Qiu X, Peng R
     Correspondence on "Role of the novel optoelectronic imaging tracing system in cervical cancer screening: preliminary outcomes of a multi-center study" by Xiao Shang et al.
     Int J Gynecol Cancer. 2025 Dec 16:102873. doi: 10.1016/j.ijgc.2025.102873.
     Abstract
     
     
221. CIBULA D, Mburu A, Planchamp F, Zapardiel I, et al
     European Society of Gynaecological Oncology resource-stratified guidelines for the management of patients with cervical cancer.
     Int J Gynecol Cancer. 2026;36:102747.
     Abstract
     
     
222. LEE SS, Banson K, Koduru H, Berger AA, et al
     Factors associated with treatment delay for cervical cancer patients treated with definitive chemoradiation and brachytherapy.
     Int J Gynecol Cancer. 2026;36:102774.
     Abstract
     
     
223. TORIGOE R, Dennen C, Mayadev J, Makale MT, et al
     Current challenges in the assessment and management of radiotherapy-induced vaginal stenosis.
     Int J Gynecol Cancer. 2026;36:102801.
     Abstract
     
     
224. MARUCCI DA SILVA GF, Pilger TL, Candido Dos Reis FJ
     Incidence of urologic co-morbidities after abdominal radical hysterectomy: a systematic review of clinical trials.
     Int J Gynecol Cancer. 2026;36:102722.
     Abstract
     
     
225. WILLIAMS G, Bindra A, Fink D, Weintraub MR, et al
     Survival in human papillomavirus and non-human papillomavirus-associated invasive endocervical adenocarcinoma: outcomes in a large, integrated healthcare system.
     Int J Gynecol Cancer. 2026;36:102683.
     Abstract
     
     
226. GAN S, Tang J, Qin S, Ou Q, et al
     Recombinant Listeria expressing the HPV multivalent E6E7 protein has a broader spectrum of anti-tumor effects against cervical cancer.
     BMC Cancer. 2025 Dec 26. doi: 10.1186/s12885-025-15476.
     Abstract
     
     
227. HAN X, Di R, Zhang H, Zhou B, et al
     Evaluation indicators for bladder dysfunction in Chinese patients following cervical cancer surgery: a Delphi study based on nursing outcomes classification.
     BMC Cancer. 2025 Dec 26. doi: 10.1186/s12885-025-15344.
     Abstract
     
     
228. KANG Y, Chang L, Lin H, Liu J, et al
     Development and external validation of a machine learning-based prognostic model for small cell neuroendocrine cervical carcinoma: a multi-center study.
     BMC Cancer. 2025 Nov 24. doi: 10.1186/s12885-025-15338.
     Abstract
     
     
229. QIU L, Xie Y, Li Y, Huang J, et al
     Association between serum gamma-Glutamyltransferase and the risk of cervical cancer: Evidence from the national health and nutrition examination survey.
     PLoS One. 2026;21:e0339001.
     Abstract
     
     
230. HU J, Wang Y, Liu Y, Cai Z, et al
     Global burden and projections of cervical cancer attributable to unsafe sex and smoking, 1990-2034.
     PLoS One. 2026;21:e0339923.
     Abstract